Home Mf Research Nippon India Pharma Fund Growth

NIPPON INDIA PHARMA FUND - GROWTH

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
Fund info
NAV (as on 2025-07-18)
522.93 -0.64%
AUM (Fund Size)
N/A
Expense Ratio
1.82%
Exit load
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units; Nil, thereafter.
Risk
N/A
AMC
NIPPON INDIA MUTUAL FUND
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-07-11 ₹1,000.00 ₹1,013.94
1.39 %
Two Week 2025-07-03 ₹1,000.00 ₹1,005.91
0.59 %
One Month 2025-06-18 ₹1,000.00 ₹1,032.90
3.29 %
Three Months 2025-04-21 ₹3,000.00 ₹3,134.62
4.49 %
Six Months 2025-01-20 ₹6,000.00 ₹6,385.28
6.42 %
One Year 2024-07-18 ₹12,000.00 ₹12,657.47
5.48 %
Three Year 2022-07-19 ₹36,000.00 ₹51,368.82
42.69 %
Five Year 2020-07-20 ₹60,000.00 ₹98,704.25
64.51 %
Ten Year 2015-07-21 ₹120,000.00 ₹320,488.37
167.07 %
Since Inception 2004-06-05 ₹258,000.00 ₹2,829,754.07
996.80 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others 2%

Sectors Holding in NIPPON INDIA PHARMA FUND - GROWTH

Healthcare Services
14%
Pharmaceuticals & Biotechnology
68%
Retailing
2%
Other
2%

Companies Holding in NIPPON INDIA PHARMA FUND - GROWTH

Apollo Hospitals Enterprise Limited
5.42%
Vijaya Diagnostic Centre Limited
3.20%
Narayana Hrudayalaya Limited
2.44%
Fortis Healthcare Limited
1.80%
Dr. Lal Path Labs Limited
1.60%
Thyrocare Technologies Limited
1.52%
Syngene International Limited
1.08%
Sun Pharmaceutical Industries Limited
13.47%
Divi's Laboratories Limited
8.39%
Lupin Limited
7.67%
Cipla Limited
6.20%
Dr. Reddy's Laboratories Limited
6.05%
Zydus Lifesciences Limited
3.92%
Gland Pharma Limited
3.70%
Abbott India Limited
3.22%
JB Chemicals & Pharmaceuticals Limited
3.03%
GlaxoSmithKline Pharmaceuticals Limited
2.98%
Ajanta Pharma Limited
2.96%
Aurobindo Pharma Limited
2.94%
Mankind Pharma Limited
2.59%
Torrent Pharmaceuticals Limited
2.27%
Sanofi India Limited
2.02%
Pfizer Limited
1.95%
Alkem Laboratories Limited
1.87%
Orchid Pharma Limited
1.11%
Sanofi Consumer Healthcare India Limited
1.09%
MedPlus Health Services Limited
2.84%
Equity Less Than 1% Of Corpus
2.12%
Cash And Other Receivables
0.56%

Risk Ratios

Std. Deviation 14.28
Beta 0.88
Sharpe Ratio 0.48
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
1.82
Expense Ratio Direct
0.92
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Sailesh Raj Bhan
more than 28 years Experience

Exit load

1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units; Nil, thereafter.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?